Osimertinib in Patients With Non-Small Cell Lung Cancer and Uncommon EGFR Mutations-Chasing Unicorns?

被引:1
|
作者
Wang, Victoria E. [1 ,2 ,4 ]
Gainor, Justin F. [3 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA USA
[3] Massachusetts Gen Hosp, Dept Med, Boston, MA USA
[4] 1825 Fourth St, Sixth Floor, San Francisco, CA 94158 USA
关键词
AFATINIB;
D O I
10.1001/jamaoncol.2023.5004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:52 / 53
页数:2
相关论文
共 50 条
  • [31] Mutations of EGFR and KRAS Genes in Belorussian Patients With Non-Small Cell Lung Cancer
    Mikhalenka, Alena
    Shchayuk, Anna
    Krupnova, Evelina
    Shapetska, Michael
    Chebotaryova, Natalia
    Pissarchik, Svetlana
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S509 - S510
  • [32] Frequency of EGFR mutations in peruvian patients with non-small cell lung cancer.
    Gomez de la Torre, Juan C.
    Storace, Angelo
    Piscocha, Christian
    Landa, Jose
    Roe, Carlos
    Roe, Eduardo
    Barletta, Claudia
    Mas, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Frequency and types of EGFR mutations in Moroccan patients with non-small cell lung cancer
    Sow, Mohamed Lemine
    El Yacoubi, Hind
    Moukafih, Badreddine
    Balde, Salif
    Akimana, Gloria
    Najem, Salma
    El Khoyaali, Siham
    Abahssain, Halima
    Chaibi, Aicha
    Khan, Shah Zeb
    Trapani, Dario
    Benzekri, Asmae
    Ghaouti, Merieme
    Gamra, Lamia
    Mestari, Amina
    Kettani, Fouad
    Rahali, Younes
    Mrabti, Hind
    Elghissassi, Ibrahim
    Errihani, Hassan
    TUMORI JOURNAL, 2021, 107 (04): : 335 - 340
  • [34] Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance
    Kai Fu
    Fachao Xie
    Fang Wang
    Liwu Fu
    Journal of Hematology & Oncology, 15
  • [35] Effectiveness of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study
    Kanazu, Masaki
    Mori, Masahide
    Kimura, Madoka
    Nishino, Kazumi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Ihara, Shoichi
    Komuta, Kiyoshi
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Kumagai, Toru
    Imamura, Fumio
    THORACIC CANCER, 2021, 12 (01) : 90 - 96
  • [36] Molecular Characteristics of the Uncommon EGFR Exon 21 T854A Mutation and Response to Osimertinib in Patients With Non-Small Cell Lung Cancer
    Zhang, Lihong
    Yang, Xia
    Ming, Zongjuan
    Shi, Jie
    Lv, Xin
    Li, Wei
    Yuan, Bo
    Chen, Yang
    Liu, Boxuan
    Qin, Kai
    Liu, Jiamin
    Wei, Qingbo
    Gu, Dejian
    Chen, Rongrong
    Yuan, Mingming
    Cui, Jean
    Ou, Sai-Hong Ignatius
    Yang, Shuanying
    CLINICAL LUNG CANCER, 2022, 23 (04) : 311 - 319
  • [37] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Alessandro Leonetti
    Sugandhi Sharma
    Roberta Minari
    Paola Perego
    Elisa Giovannetti
    Marcello Tiseo
    British Journal of Cancer, 2019, 121 : 725 - 737
  • [38] Tackling Osimertinib Resistance in EGFR-Mutant Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Ortiz-Cuaran, Sandra
    Ricciuti, Biagio
    Mezquita, Laura
    Cardona, Andres Felipe
    Recondo, Gonzalo
    CLINICAL CANCER RESEARCH, 2023, 29 (18) : 3579 - 3591
  • [39] Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
    Leonetti, Alessandro
    Sharma, Sugandhi
    Minari, Roberta
    Perego, Paola
    Giovannetti, Elisa
    Tiseo, Marcello
    BRITISH JOURNAL OF CANCER, 2019, 121 (09) : 725 - 737
  • [40] EGFR Array: Uses in the Detection of Plasma EGFR Mutations in Non-Small Cell Lung Cancer Patients
    Yam, Irene
    Lam, David Chi-Leung
    Chan, Kaimin
    Ho, James Chung-Man
    Ip, Mary
    Lam, Wah-Kit
    Chan, Tai-Kwong
    Chan, Vivian
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1131 - 1140